Protecting and storing temperature-sensitive medications, such as insulin, can be both risky and challenging. Pharmaceutical companies, hospitals, and pharmacies have their ways of preserving the medicines’ temperature. But once insulin is taken home and in use by the patients, the insulin is at risk of becoming damaged if not kept at the correct temperatures at all times. When insulin is subjected to excessive heat or cold, it can become spoiled and put patients at risk.
According to a study posted on the PubMed website of the U.S. Department of Health and Human Services, the improper storage of insulin can decrease its potency and pharmacological action. The study also suggests that patients should be educated on the correct storage methods to avoid the risk of injecting compromised insulin.
Knowing this, TempraMed created an easy-to-use and hassle-free smart device that keeps insulin within the safe zones of its required temperature of insulin in use. TempraMed is a company that develops, manufactures, and markets smart medical devices that protect patients from compromised medications due to improper storage and exposure to extreme temperatures.
TempraMed’s smart device called VIVI Cap 1 is a reusable insulin cooler cap that is scientifically proven to protect insulin from extreme temperatures. It is made with TempraMed’s patented technology that combines unique insulation and heat-absorbing materials that are monitored and controlled by a customized electronics system. This technology is the first of its kind and is proven to meet the requirements for last-mile control for pharmaceuticals. The ‘last mile’ refers to the product’s final leg of the journey.
TempraMed VIVI Cap 1 has a built-in temperature sensor with an easy-to-read temperature indicator. It is small and lightweight and it perfectly fits in the purse or even in the pocket. TempraMed VIVI Cap 1 can work every day for years without maintenance and does not require battery charging or any water, ice pack, or refrigeration. It is available all around the world and comes in two variations—a temperature shield cap for pre-filled insulin pens and a version for refillable insulin pens.
TempraMed’s advanced technology enables the company to provide last-mile control management for all temperature-sensitive medications. Through this, the company is taking care of patients and keeping them safe from the dangers of compromised medication due to threatening temperatures.
With the success of VIVI Cap 1, TempraMed plans to release other smart devices that are developed through the same TempraMed patented technology. These devices are developed to protect and store other injectors, vials, and pens. These include VIVI Box, VIVI Vial, VIVI Epi, VIVI Vial 8C, VIVI Cool 8C, and VIVI Cap Smart.
TempraMed creates easy-to-use and hassle-free solutions that protect patients from getting damaged medications. The company develops, manufactures, and markets these smart medical devices in more than ten countries worldwide.